Extensive evidence demonstrates that lowering blood pressure can substantially reduce the risk of atherosclerotic cardiovascular disease and death.In light of the latest 2018 European Society of Cardiology/European Society of Hypertension Joint Guidelines, we summarize the current recommendations about lifestyle intervention strategies, pharmacotherapy, and device-based treatments for the management of arterial hypertension. Special attention is given to direct effects exerted by some antihypertensive drugs targeting vascular wall cell components that are involved in the pathogenesis of atherosclerosis
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
A symposium held at the 29th European Meeting on Hypertension and Cardiovascular Protection in Milan...
Hypertension, the most common preventable risk factor for cardiovascular disease and death, is a gro...
Hypertension, the most common preventable risk factor for cardiovascular disease and death, is a gro...
BACKGROUND: Essential arterial hypertension is one of the main treatable cardiovascular risk fac...
Arterial hypertension is the main identifiable cardiovascular risk factor, and although the benefit...
BACKGROUND: Essential arterial hypertension is one of the main treatable cardiovascular risk fac...
The aim of the treatment of hypertensive disease is to reduce its associated cardiovascular morbidit...
The aim of the treatment of hypertensive disease is to reduce its associated cardiovascular morbidit...
Systemic arterial hypertension is the most important modifiable risk factor for all-cause morbidity ...
Background: High blood pressure is the main risk factor worldwide for mortality and morbidity. Subje...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
A symposium held at the 29th European Meeting on Hypertension and Cardiovascular Protection in Milan...
Hypertension, the most common preventable risk factor for cardiovascular disease and death, is a gro...
Hypertension, the most common preventable risk factor for cardiovascular disease and death, is a gro...
BACKGROUND: Essential arterial hypertension is one of the main treatable cardiovascular risk fac...
Arterial hypertension is the main identifiable cardiovascular risk factor, and although the benefit...
BACKGROUND: Essential arterial hypertension is one of the main treatable cardiovascular risk fac...
The aim of the treatment of hypertensive disease is to reduce its associated cardiovascular morbidit...
The aim of the treatment of hypertensive disease is to reduce its associated cardiovascular morbidit...
Systemic arterial hypertension is the most important modifiable risk factor for all-cause morbidity ...
Background: High blood pressure is the main risk factor worldwide for mortality and morbidity. Subje...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
In 2007 the European Society of Hypertension, the American Heart Association and the International S...
A symposium held at the 29th European Meeting on Hypertension and Cardiovascular Protection in Milan...